Yaqiu Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yaqiu Wu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Meixiong Cheng
Department of Neurosurgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, PR China
4 shared publicationsTian Zhang
Department of Neurosurgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, PR China
3 shared publicationsLing Liu
Department of Neurosurgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, PR China
2 shared publicationsMin Xu
Department of Neurosurgery Critical Care Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, P.R. China
2 shared publicationsYi Zeng
Department of Neurosurgery Critical Care Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, P.R. China
2 shared publications- Zhili Li
Department of Neurosurgery, School of Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
2 shared publications
Latest Publications
- 3 January 2022
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 38 (4) , 649-665
Mesenchymal stem cell-derived extracellular vesicles prevent glioma by blocking M2 polarization of macrophages through a miR-744-5p/TGFB1-dependent mechanism
Aim Our current study is conducted with intention to explore the regulatory mechanism of mesenchymal stem cell (MSC)-derived extracellular vesicle (EV)-miR-744-5p in glioma. Methods Expression patterns of TGFB1, TGFBR1, and miR-744-5p were determined. EVs were isolated from human MSCs, which were characterized. Then, macrophages were co-cultured with MSCs with ectopic miR-744-5p expression to explore its role in cell proliferation, invasion, and migration capabilities. A nude mouse model of glioma xenograft was developed to observe the tumorigenesis and metastasis ability of glioma in vivo. Results TGFB1 and TGFBR1 were upregulated in glioma. TGFB1 promoted M2 polarization of macrophages through theMAPK signaling, thereby promoting the progression of glioma. MSC-EVs suppressed TGFB1 expression in macrophages and inhibited M2 polarization of macrophages. MSC-EVs-miR-744-5p/TGFB1/MAPK axis inhibited M2 polarization of macrophages and reduced the malignant phenotypes of glioma cells. In vivo experiments verified that MSC-EVs-miR-744-5p inhibited the polarization of macrophage M2 and prevented glioma progression. Conclusion Taken together, MSC-EVs-miR-744-5p may suppress the MAPK signaling activity by downregulating TGFB1, and then inhibit polarization of macrophages M2, thereby preventing the progression of glioma. Graphical abstract Graphical Headlights 1. TGFB1 promotes the M2 polarization of macrophages via the MAPK signaling. 2. miR-744-5p carried by MSC-EVs targets and inhibits TGFB1. 3. MSC-EV-miR-744-5p inhibits M2 polarization of macrophages to prevent glioma progression. 4. miR-744-5p loaded by MSC-EVs may be a preventive strategy against glioma.
- 3 January 2022
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 38 (4) , 649-665
Mesenchymal stem cell-derived extracellular vesicles prevent glioma by blocking M2 polarization of macrophages through a miR-744-5p/TGFB1-dependent mechanism
Aim Our current study is conducted with intention to explore the regulatory mechanism of mesenchymal stem cell (MSC)-derived extracellular vesicle (EV)-miR-744-5p in glioma. Methods Expression patterns of TGFB1, TGFBR1, and miR-744-5p were determined. EVs were isolated from human MSCs, which were characterized. Then, macrophages were co-cultured with MSCs with ectopic miR-744-5p expression to explore its role in cell proliferation, invasion, and migration capabilities. A nude mouse model of glioma xenograft was developed to observe the tumorigenesis and metastasis ability of glioma in vivo. Results TGFB1 and TGFBR1 were upregulated in glioma. TGFB1 promoted M2 polarization of macrophages through theMAPK signaling, thereby promoting the progression of glioma. MSC-EVs suppressed TGFB1 expression in macrophages and inhibited M2 polarization of macrophages. MSC-EVs-miR-744-5p/TGFB1/MAPK axis inhibited M2 polarization of macrophages and reduced the malignant phenotypes of glioma cells. In vivo experiments verified that MSC-EVs-miR-744-5p inhibited the polarization of macrophage M2 and prevented glioma progression. Conclusion Taken together, MSC-EVs-miR-744-5p may suppress the MAPK signaling activity by downregulating TGFB1, and then inhibit polarization of macrophages M2, thereby preventing the progression of glioma. Graphical abstract Graphical Headlights 1. TGFB1 promotes the M2 polarization of macrophages via the MAPK signaling. 2. miR-744-5p carried by MSC-EVs targets and inhibits TGFB1. 3. MSC-EV-miR-744-5p inhibits M2 polarization of macrophages to prevent glioma progression. 4. miR-744-5p loaded by MSC-EVs may be a preventive strategy against glioma.
- Open Access
- 1 March 2021
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 23, 418-430
Transcription Factor ELF1 Activates MEIS1 Transcription and Then Regulates the GFI1/FBW7 Axis to Promote the Development of Glioma
- 1 March 2021
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 23, 418-430
Open AccessTranscription Factor ELF1 Activates MEIS1 Transcription and Then Regulates the GFI1/FBW7 Axis to Promote the Development of Glioma
- Open Access
- 20 April 2020
- Published by Springer Nature in Research Square
ELF1 upregulates MEIS1 to accelerate proliferation, migration and invasion of glioma cells through the GFI1/FBW7 axis
Background: To explore whether the transcription factor ELF1 affects the GFI1-FBW7 through MEIS1, thus participating in the occurrence and development of glioma. In this study, key transcription factors were identified by differential analysis of GEO database, and downstream regulatory pathways were predicted by available literature.Methods and results: Based on bioinformatics analysis and existing studies, we speculate that the transcription factor ELF1 may regulate FBW7 through MEIS1-mediated GFI1 and thus affect the occurrence of glioma. The expressions of transcription factors ELF1, MEIS1 and GFI1 were up-regulated in glioma tissues, and the prognosis of glioma patients with high expression of ELF1 was worse.We found that interfering with ELF1 expression in glioma cells can reduce the proliferation, migration and invasion of tumor cells and induce cell apoptosis. The results of Western-blot showed that the expressions of PCNA and MMP9 were decreased, while the expression of cleaved caspase-3 was up-regulated. ChIP experiments showed that ELF1 binds to the MEIS1 promoter region, and MEIS1 can activate the enhancer of GFI1. In vivo experiments were carried out in nude mice, the results showed that interfering ELF1 could inhibit tumor growth in nude mice through the MEIS1-GFI1/FBW7.Conclusion: Therefore, interference of ELF1 in glioma can reduce its ability to recruit the transcription factor MEIS1, and further impair the activation ability of MEIS1 to GFI1 enhancer, which resulting in suppression of proliferation, migration and invasion and induction of cell apoptosis in glioma cells.
- 20 April 2020
- Published by Springer Nature in Research Square
Open AccessELF1 upregulates MEIS1 to accelerate proliferation, migration and invasion of glioma cells through the GFI1/FBW7 axis
Background: To explore whether the transcription factor ELF1 affects the GFI1-FBW7 through MEIS1, thus participating in the occurrence and development of glioma. In this study, key transcription factors were identified by differential analysis of GEO database, and downstream regulatory pathways were predicted by available literature.Methods and results: Based on bioinformatics analysis and existing studies, we speculate that the transcription factor ELF1 may regulate FBW7 through MEIS1-mediated GFI1 and thus affect the occurrence of glioma. The expressions of transcription factors ELF1, MEIS1 and GFI1 were up-regulated in glioma tissues, and the prognosis of glioma patients with high expression of ELF1 was worse.We found that interfering with ELF1 expression in glioma cells can reduce the proliferation, migration and invasion of tumor cells and induce cell apoptosis. The results of Western-blot showed that the expressions of PCNA and MMP9 were decreased, while the expression of cleaved caspase-3 was up-regulated. ChIP experiments showed that ELF1 binds to the MEIS1 promoter region, and MEIS1 can activate the enhancer of GFI1. In vivo experiments were carried out in nude mice, the results showed that interfering ELF1 could inhibit tumor growth in nude mice through the MEIS1-GFI1/FBW7.Conclusion: Therefore, interference of ELF1 in glioma can reduce its ability to recruit the transcription factor MEIS1, and further impair the activation ability of MEIS1 to GFI1 enhancer, which resulting in suppression of proliferation, migration and invasion and induction of cell apoptosis in glioma cells.